Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
MCKINNELL HENRY ADirector
|
GrantCommon Stock | 109 | $287.23 | $31,308.07 |
DisclosureSEC source: 0001209191-21-022050 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,471.388 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
Seidman LeslieDirector
|
GrantCommon Stock | 14 | $287.23 | $4,021.22 |
DisclosureSEC source: 0001209191-21-022049 · doc4.xml · nonDerivative · entry 1 Seidman Leslie · CIK 0001595268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,646 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
MCDANIEL RAYMOND WDirector
|
GrantDividend Equivalent · Derivative | 1.896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022047 · doc4.xml · derivative · entry 1 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.896 Underlying: Common Stock · 1.896 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F1 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F1 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
Hill KathrynDirector
|
GrantDividend Equivalent · Derivative | 1.393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022048 · doc4.xml · derivative · entry 1 Hill Kathryn · CIK 0001533931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.393 Underlying: Common Stock · 1.393 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F1 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F1 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
Esperdy ThereseDirector
|
GrantDividend Equivalent · Derivative | 1.393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022045 · doc4.xml · derivative · entry 2 Esperdy Therese · CIK 0001767289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.393 Underlying: Common Stock · 1.393 shares Expires not disclosed F2 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F2 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F2 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
Esperdy ThereseDirector
|
GrantCommon Stock | 9.531 | $289.39 | $2,758.18 |
DisclosureSEC source: 0001209191-21-022045 · doc4.xml · nonDerivative · entry 1 Esperdy Therese · CIK 0001767289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,360.338 F1 · shares: RSU deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
FORLENZA VINCENT ADirector
|
GrantDividend Equivalent · Derivative | 1.393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022046 · doc4.xml · derivative · entry 3 FORLENZA VINCENT A · CIK 0001221787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.393 Underlying: Common Stock · 1.393 shares Expires not disclosed F5 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F5 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F5 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
FORLENZA VINCENT ADirector
|
GrantPhantom Stock Units (Deferred Compensation) · Derivative | 0.99 | $287.61 | $284.73 |
DisclosureSEC source: 0001209191-21-022046 · doc4.xml · derivative · entry 2 FORLENZA VINCENT A · CIK 0001221787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470.75 Underlying: Common Stock · 0.99 shares Expires not disclosed F2 · security: Phantom Stock Units arising out of the Reporting Person's election to defer receipt of retainer fees. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in cash after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in cash after the Reporting Person's retirement. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
FORLENZA VINCENT ADirector
|
GrantCommon Stock | 12.013 | $289.39 | $3,476.44 |
DisclosureSEC source: 0001209191-21-022046 · doc4.xml · nonDerivative · entry 1 FORLENZA VINCENT A · CIK 0001221787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,006.369 F1 · shares: RSU deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
Bermudez Jorge A.Director
|
GrantCommon Stock | 16 | $287.23 | $4,595.68 |
DisclosureSEC source: 0001209191-21-022044 · doc4.xml · nonDerivative · entry 1 Bermudez Jorge A. · CIK 0001419202 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,838 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
ANDERSON BASILDirector
|
GrantDividend Equivalent · Derivative | 1.393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022043 · doc4.xml · derivative · entry 4 ANDERSON BASIL · CIK 0001180659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.393 Underlying: Common Stock · 1.393 shares Expires not disclosed F6 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F6 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. F6 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
ANDERSON BASILDirector
|
GrantPhantom Stock Units (Deferred Compensation) · Derivative | 25.75 | $287.61 | $7,405.96 |
DisclosureSEC source: 0001209191-21-022043 · doc4.xml · derivative · entry 3 ANDERSON BASIL · CIK 0001180659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,189.65 Underlying: Common Stock · 25.75 shares Expires not disclosed F3 · security: Phantom Stock Units arising out of the Reporting Person's election to defer receipt of retainer fees. F4 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: These units are to be settled in cash after the Reporting Person's retirement. F5 · derivative.expiration_date: These units are to be settled in cash after the Reporting Person's retirement. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
ANDERSON BASILDirector
|
GrantCommon Stock | 11.931 | $289.39 | $3,452.71 |
DisclosureSEC source: 0001209191-21-022043 · doc4.xml · nonDerivative · entry 2 ANDERSON BASIL · CIK 0001180659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,529.054 F2 · shares: RSU deferred dividend reinvestment accrual. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:00 UTC |
ANDERSON BASILDirector
|
GrantCommon Stock | 86 | $287.23 | $24,701.78 |
DisclosureSEC source: 0001209191-21-022043 · doc4.xml · nonDerivative · entry 1 ANDERSON BASIL · CIK 0001180659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,517.123 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,435 | $0.00 Strike: $80.81 | $0.00 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · derivative · entry 8 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,435 shares Expires 2026-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. F3 · derivative.exercise_date: One fourth of the options vested each year beginning with the date indicated. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,908 | $0.00 Strike: $79.55 | $0.00 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · derivative · entry 7 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,908 shares Expires 2024-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. F3 · derivative.exercise_date: One fourth of the options vested each year beginning with the date indicated. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
SaleCommon Stock | 51 | $295.40 | $15,065.15 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 6 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,381 F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
SaleCommon Stock | 1,460 | $294.31 | $429,696.98 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 5 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,432 F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. F2 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $294.08 to $294.78. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
SaleCommon Stock | 3,800 | $292.84 | $1,112,792.00 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 4 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,892 F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
Exercise / conversionCommon Stock | 8,435 | $80.81 | $681,632.35 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 3 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
SaleCommon Stock | 6,216 | $294.27 | $1,829,188.54 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 2 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,257 F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:32 UTC |
GOGGINS JOHN JEVP and General Counsel
|
Exercise / conversionCommon Stock | 9,908 | $79.55 | $788,181.40 |
DisclosureSEC source: 0001209191-21-022142 · doc4.xml · nonDerivative · entry 1 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:08 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 611 | $294.38 | $179,866.18 |
DisclosureSEC source: 0001209191-21-020755 · doc4.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611 F1 · shares: Exempt grant of restricted stock units. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 21:13 UTC |
MCDANIEL RAYMOND WDirector
|
SaleTransaction | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020934 · doc4.xml · nonDerivative · entry 3 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,014 F4 · kind: Sale of shares pursuant to a pre-arranged plan. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 21:13 UTC |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 1,693 | $291.21 | $493,025.30 |
DisclosureSEC source: 0001209191-21-020934 · doc4.xml · nonDerivative · entry 2 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,014 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. F3 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $291.04 to $291.53. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 21:13 UTC |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 3,700 | $290.51 | $1,074,868.50 |
DisclosureSEC source: 0001209191-21-020934 · doc4.xml · nonDerivative · entry 1 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,707 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. F2 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $290.00 to $290.94. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2021 Filed Mar 29, 2021 20:51 UTC Amendment |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 14,000 | $306.97 | $4,297,580.00 |
DisclosureSEC source: 0001209191-21-023455 · doc4a.xml · nonDerivative · entry 2 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,014 F1 · kind: Sale of shares pursuant to a pre-arranged plan. F2 · price: The reporting person contributed common stock to an exchange fund in exchange for shares of the exchange fund. The closing of the exchange fund was subject to conditions not controlled by the reporting person, and occurred on March 29, 2021, with a valuation of $306.97 per share, which was reported to the reporting person on March 29, 2021. Read SEC document |
| March 12, 2021 Filed Mar 31, 2021 20:00 UTC Amendment |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 11,480 | $306.97 | $3,524,015.60 |
DisclosureSEC source: 0001209191-21-023756 · doc4a.xml · nonDerivative · entry 2 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,534 F1 · kind: Sale of shares pursuant to a pre-arranged plan. F2 · shares: The reporting person contributed common stock to an exchange fund in exchange for shares of the exchange fund. The closing of the exchange fund was subject to conditions not controlled by the reporting person, and occurred on March 29, 2021, with a valuation of $306.97 per share, which was reported to the reporting person on March 29, 2021, and with the exchange fund subsequently reporting that the number of shares accepted was lower than initially reported. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:00 UTC |
Tulenko Stephen TPresident, Moody's Analytics
|
SaleCommon Stock | 1,500 | $291.50 | $437,250.00 |
DisclosureSEC source: 0001209191-21-019762 · doc4.xml · nonDerivative · entry 1 Tulenko Stephen T · CIK 0001790871 · President, Moody's Analytics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,582.49 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:00 UTC |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 100 | $280.36 | $28,035.50 |
DisclosureSEC source: 0001209191-21-018505 · doc4.xml · nonDerivative · entry 3 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,407 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:00 UTC |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 1,193 | $279.50 | $333,437.54 |
DisclosureSEC source: 0001209191-21-018505 · doc4.xml · nonDerivative · entry 2 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,507 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. F3 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $279.26 to $279.74. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:00 UTC |
MCDANIEL RAYMOND WDirector
|
SaleCommon Stock | 4,100 | $278.74 | $1,142,834.00 |
DisclosureSEC source: 0001209191-21-018505 · doc4.xml · nonDerivative · entry 1 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,700 F1 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. F2 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $278.23 to $279.22. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:00 UTC |
Sullivan CarolineSVP-Corporate Controller
|
SaleCommon Stock | 394 | $282.87 | $111,449.60 |
DisclosureSEC source: 0001209191-21-016778 · doc4.xml · nonDerivative · entry 2 Sullivan Caroline · CIK 0001759006 · SVP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910.39 F2 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $282.83 to $282.90. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:00 UTC |
Kaye MarkSVP & Chief Financial Officer
|
SaleCommon Stock | 1,065 | $280.85 | $299,105.25 |
DisclosureSEC source: 0001209191-21-016776 · doc4.xml · nonDerivative · entry 3 Kaye Mark · CIK 0001748691 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,989 F3 · kind: Sale of shares pursuant to Rule 10b5-1 Plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:00 UTC |
West Michael LPresident, Moody's Investors
|
SaleCommon Stock | 2,000 | $282.90 | $565,800.00 |
DisclosureSEC source: 0001209191-21-016772 · doc4.xml · nonDerivative · entry 9 West Michael L · CIK 0001791243 · President, Moody's Investors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,963.997 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Tulenko Stephen TPresident, Moody's Analytics
|
Tax withholdingCommon Stock | 1,814 | $280.63 | $509,062.82 |
DisclosureSEC source: 0001209191-21-016781 · doc4.xml · nonDerivative · entry 2 Tulenko Stephen T · CIK 0001790871 · President, Moody's Analytics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,082.488 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Tulenko Stephen TPresident, Moody's Analytics
|
GrantCommon Stock | 2,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016781 · doc4.xml · nonDerivative · entry 1 Tulenko Stephen T · CIK 0001790871 · President, Moody's Analytics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,896.488 F1 · shares: Receipt of shares acquired upon settlement of 2018-2020 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
MCDANIEL RAYMOND WDirector
|
Tax withholdingCommon Stock | 12,272 | $280.63 | $3,443,891.36 |
DisclosureSEC source: 0001209191-21-016780 · doc4.xml · nonDerivative · entry 2 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,800 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
MCDANIEL RAYMOND WDirector
|
GrantCommon Stock | 23,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016780 · doc4.xml · nonDerivative · entry 1 MCDANIEL RAYMOND W · CIK 0001195306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,072 F1 · shares: Receipt of shares acquired upon settlement of 2018 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Fauber RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 3,215 | $280.63 | $902,225.45 |
DisclosureSEC source: 0001209191-21-016774 · doc4.xml · nonDerivative · entry 2 Fauber Robert · CIK 0001481153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,598 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Fauber RobertDirector · President and CEO
|
GrantCommon Stock | 4,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016774 · doc4.xml · nonDerivative · entry 1 Fauber Robert · CIK 0001481153 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,813 F1 · shares: Receipt of shares acquired upon settlement of 2018-2020 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Sullivan CarolineSVP-Corporate Controller
|
Tax withholdingCommon Stock | 83 | $280.63 | $23,292.29 |
DisclosureSEC source: 0001209191-21-016778 · doc4.xml · nonDerivative · entry 1 Sullivan Caroline · CIK 0001759006 · SVP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304.39 F1 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Hughes MelanieSVP & Chief HR Officer
|
SaleCommon Stock | 2,168 | $280.61 | $608,358.14 |
DisclosureSEC source: 0001209191-21-016777 · doc4.xml · nonDerivative · entry 3 Hughes Melanie · CIK 0001380530 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,965.157 F3 · price: The price reported in Column 4 is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $280.54 to $280.80. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Hughes MelanieSVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,229 | $280.63 | $344,894.27 |
DisclosureSEC source: 0001209191-21-016777 · doc4.xml · nonDerivative · entry 2 Hughes Melanie · CIK 0001380530 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,133.157 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Hughes MelanieSVP & Chief HR Officer
|
GrantCommon Stock | 2,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016777 · doc4.xml · nonDerivative · entry 1 Hughes Melanie · CIK 0001380530 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,362 F1 · shares: Receipt of shares acquired upon settlement of 2018-2020 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
GOGGINS JOHN JEVP and General Counsel
|
Tax withholdingCommon Stock | 1,972 | $280.63 | $553,402.36 |
DisclosureSEC source: 0001209191-21-016775 · doc4.xml · nonDerivative · entry 2 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,565 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
GOGGINS JOHN JEVP and General Counsel
|
GrantCommon Stock | 3,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016775 · doc4.xml · nonDerivative · entry 1 GOGGINS JOHN J · CIK 0001195304 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,537 F1 · shares: Receipt of shares acquired upon settlement of 2018-2020 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Kaye MarkSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,340 | $280.63 | $656,674.20 |
DisclosureSEC source: 0001209191-21-016776 · doc4.xml · nonDerivative · entry 2 Kaye Mark · CIK 0001748691 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,054 F2 · shares: Disposition of shares to satisfy tax withholding obligation. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Kaye MarkSVP & Chief Financial Officer
|
GrantCommon Stock | 3,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016776 · doc4.xml · nonDerivative · entry 1 Kaye Mark · CIK 0001748691 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394 F1 · shares: Receipt of shares acquired upon settlement of 2018-2020 Performance Shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
West Michael LPresident, Moody's Investors
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,972 | $0.00 Strike: $173.58 | $0.00 |
DisclosureSEC source: 0001209191-21-016772 · doc4.xml · derivative · entry 12 West Michael L · CIK 0001791243 · President, Moody's Investors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,972 shares Expires 2029-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One fourth of options vest each year beginning with the date indicated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.